Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Haisch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contractionJ H Fleisch, K D Haisch, S M Spaethe
Agents and Actions|February 1, 1987
Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
Journal of Pharmacological Methods|August 1, 1981
Schultz-Dale reaction in mouse tracheaG A Koppel, K D Haisch, S M Spaethe, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1986
Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4J H Fleisch, L E Rinkema, K D Haisch, et al.
Journal of Medicinal Chemistry|May 1, 1987
Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivativesR D Dillard, F P Carr, D McCullough, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonistD K Herron, C A Whitesitt, B E Mallet, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
Journal of Medicinal Chemistry|April 1, 1987
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivativesW S Marshall, T Goodson, G J Cullinan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) releaseJ H Fleisch, K D Haisch, S M Spaethe, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contractionJ H Fleisch, K D Haisch, S M Spaethe
Agents and Actions|February 1, 1987
Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
Journal of Pharmacological Methods|August 1, 1981
Schultz-Dale reaction in mouse tracheaG A Koppel, K D Haisch, S M Spaethe, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1986
Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4J H Fleisch, L E Rinkema, K D Haisch, et al.
Journal of Medicinal Chemistry|May 1, 1987
Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivativesR D Dillard, F P Carr, D McCullough, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonistD K Herron, C A Whitesitt, B E Mallet, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
Journal of Medicinal Chemistry|April 1, 1987
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivativesW S Marshall, T Goodson, G J Cullinan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) releaseJ H Fleisch, K D Haisch, S M Spaethe, et al.
Pageof 1